State reaches deal with pharmacy to extend price cuts on opioid antidote

New York State Attorney General announced a deal with Amphastar Pharmaceuticals Inc. that will extend price cuts for naloxone, an antidote that is helping agencies across the state combat opioid overdoses.

The rebate is available to all public agencies including drug treatment centers, State Department of Health, the governments of individual New York Counties, and harm reduction programs.

"We need every tool at our disposal to respond to the opioid addiction crisis, and that includes making sure that live-saving medication like naloxone is available to first responders who are on the front lines to treat victims of overdose," said Attorney General Schneiderman

The deal between the state and Amphastar Pharmaceuticals Inc. will go through January of 2018.

Because of the price cuts, more than 200 agencies across the state were able to save $1.6 million dollars on naloxone syringes since 2015.